The impact of antibiotics on total endotoxemia and circulating tumor necrosis factor (TNF)-a, interleukin (IL)-6, and IL-8 in 18 patients with severe bacteremic sepsis or septic shock due to gram-negative species was investigated. Endotoxemia, TNF-a, IL-6, and IL-8 were assayed before (H0) and 1 h (H1) and 4 h (H4) after the first antibiotic infusion. Endotoxemia decreased from H0 (median, 0.4 EU/mL; interquartile interval, 0.09 -1.23) to H1 (median, 0.19 EU/mL; interquartile interval, 0.07 -0.75; P Å .03) and remained stable between H1 and H4 (median, 0.12 EU/mL; interquartile interval, 0.09 -0.30; P Å .4). IL-6 levels fell between H0 and H4 (P Å .01) and between H1 and H4 (P Å .03). IL-8 was higher at H0 than at H1 (P Å .04) and at H4 (P Å .01). These results suggest that endotoxemia is not increased by antibiotherapy of severe gram-negative bacteremia. 
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systolic blood pressure õ90 mm Hg or a fall in systolic blood
Experimental observations have demonstrated that endotoxin pressure of at least 40 mm Hg from baseline; acute oliguria (õ30 is strongly involved in the pathophysiology of sepsis caused mL/h or õ0.7 L/day); arterial blood pH õ7.36 or hyperlactatemia;
by gram-negative bacteria [1] . The toxicity of endotoxin would severe gram-negative bacteremic sepsis.
Antibiotic therapy was chosen according to clinical status. Antibiotics were administered intravenously. When several antibiotics were used they were given simultaneously.
Methods
Patients could be enrolled 24 h a day, as blood samples were obtained and centrifuged by the attending physician. Survivors are Patients. All consecutive patients admitted to our unit from 1 defined as patients alive 30 days after admission to our unit. January 1995 to 1 June 1996 for severe sepsis or septic shock [4] Blood culture. Blood (10 mL) was placed in each of two aerosuspected to be due to gram-negative species were eligible. Severe bic and anaerobic bottles (BacT Alert; Organon Teknika, Durham, sepsis was defined by at least two of the following criteria: temper-NC). When growth was detected, microorganisms were identified ature õ36ЊC or ú38ЊC, heart rate ú90 bpm, respiratory rate ú20/ by use of the Api 20 E system (Biomérieux, Marcy-l'Etoile, min, and leukocytosis ú12,000/mm 3 or õ4000/mm 3 . In addition, France). these criteria had to be associated with at least one of the following:
Blood sampling. Blood sampling for endotoxin and for cytokine assays (TNF-a, IL-6, IL-8) was done just before the first antibiotic infusion (H0), and 1 h (H1) and 4 h (H4) after the end of the infusion. on ice and then rapidly centrifuged (190 g for 10 min at 4ЊC); the Clinical outcome. All 5 deaths occurred within 24 h folplatelet-rich plasma was carefully separated and stored at 020ЊC lowing admission; 2 patients died of refractory shock õ4 h until endotoxin assay. The endotoxin concentration was derived after admission, and full blood samples could not be obtained.
from a previously described chromogenic end-point limulus assay
Species isolated and primary sites of infection.
A microbi- [6] . The detection limit was 0.06 EU/mL (5 pg/mL). The withinologically proven primary site of infection was found in each and between-assay variation coefficients of the assay at 100 pg/ patient. Peritonitis was diagnosed by culturing peritoneal fluid mL of platelet-rich plasma were 6% and 5%, respectively. At obtained during surgery or bedside centesis. Pulmonary infec-10 pg/mL of platelet-rich plasma, values of 10% and 15% were tion was diagnosed by quantitative culture of the tip of a proobtained.
tected brush during pulmonary fibroscopy.
Cytokine levels were determined with specific ELISA kits.
Antibiotic therapy. Antibiotics and bacterial species are
Plasma IL-8 was measured with a previously described method listed in table 1. Antibiotic infusions never lasted ú1 h. Amino- [7] , whereas IL-6 and TNF-a were measured according to the glycosides were administered intravenously once daily. All manufacturer's instructions (R&D Systems, Minneapolis). The detection limits were õ10 pg/mL for IL-8, 45 pg/mL for IL-6, and bacteria isolated from blood were sensitive to at least one of 20 pg/mL for TNF-a. the prescribed antibiotics. the limulus value was above the detection limit (0.06 EU/mL) in all 17 analyzed patients (range, 0.06-4.1 EU/mL). Endotoxin Results was undetectable at H1 in 3 patients. The mean H4 endotoxin During the study period, among 54 patients included, 18 (10 value was calculated from 15 patients, because 2 patients died men; mean age, 57 { 20 years; SAPS II, 37 { 18) had docubefore this time point. Among the 15 patients with assessable mented gram-negative bacteremia with severe sepsis or septic samples at H4, 4 had levels below the detection limit (3 had shock. Thirteen patients were in shock on admission. The charundetectable levels at H1). When the 17 evaluable patients were acteristics of these 18 patients are shown in table 1. Patient 10 individually analyzed, 3 of them had more endotoxin after than before the first antibiotic infusion. Two of them had a favorable presented with jaundice related to chronic cholestasis.
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05-28-98 08:11:50 jinfas UC: J Infect outcome without worsening of hemodynamic status, whereas from intensive care patients with numerous co-morbidities and immunosuppressive therapies. the third (patient 15) experienced a 10-fold increase in endotoxemia (0.07 to 0.7 EU/mL) between H0 and H4.
Endotoxin levels were found to be similar to those observed in previous clinical studies but were lower than those obtained Proinflammatory cytokines. Circulating cytokine levels are given in table 2. Mean values were calculated for all 18 patients, in experimental studies. Experimental studies may not therefore be entirely relevant to the clinical setting. Circulating endotoxin except at H4 because 2 patients died before the samplings could be done. All mean cytokine levels (TNF-a, IL-6 and IL-8) meawas measured 1 and 4 h after the onset of antibiotherapy, because the effect of agents acting on the bacterial cell wall sured after antibiotic infusion were lower than those measured before. Individual analysis disclosed no increase in circulating begins very early, given the very short doubling time (20 min) of gram-negative bacteria. cytokines after antibiotic infusion except for patient 15, who experienced a 2-fold increase in TNF-a between H1 and H4.
We found that total endotoxemia fell after first infusion of antibiotics. Similar data have been reported by Brandtzaeg et urosepsis during treatment with imipenem or ceftazidime, Prins et al.
[9] detected endotoxin at baseline in only 3 patients of the imipenem group and in 4 patients of the ceftazidime group. An Discussion increase in total endotoxemia (4 h after antibiotic infusion) was Circulating endotoxin levels correlate weakly with outcome reported only among 2 of the 4 endotoxemic patients receiving in gram-negative bacterial sepsis [6] . However, it is assumed ceftazidime, and this without any clinical impact. that any fall in endotoxemia would have a positive impact In a nonprospective work, Shenep et al. [10] reported an in gram-negative bacteria -related sepsis. Whereas numerous increase in endotoxemia in 7 bacteremic patients after antibiexperimental studies have demonstrated excess release of endootherapy, but this increase was relevant only for the free form toxin during antibiotic therapy, the clinical relevance of such of endotoxin. The fact that a gelation assay was used in this an effect, and even its very existence in humans, remains to work to measure endotoxin while we used a chromogenic be established. This discrepancy between experimental and method may also contribute to explain this discrepancy. clinical observations may be related to several reasons. First, Dofferhoff et al.
[11] observed a shift from cell-bound to it is impossible to compare in vitro studies, in which an increase free endotoxin in 10 endotoxemic patients, only 4 of whom in endotoxin always reflects only a release of endotoxin, with had gram-negative bacteremia. However, an increase in total in vivo studies, in which circulating endotoxin depends on both endotoxin followed by clinical worsening occurred only in 2 bacterial production and peripheral captation (e.g., mononupatients. clear cells, liver). Second, intraperitoneal or intravenous inocuTaken together, these data show that cell-bound and free endolation of gram-negative species, during which an increase in toxin should be distinguished. Experimental studies have sugendotoxemia has been observed, is far from human infection.
gested that free endotoxin is more active than the cell-bound form Third, experimental studies are generally conducted among [12] . However, even if cell-bound endotoxin accounts for õ10% of the total biologic activity of endotoxin in vitro [12] , the cellyoung, healthy, and homogeneous animals, which differ greatly / 9d4a$$jy27 05-28-98 08:11:50 jinfas UC: J Infect
